XML 12 R3.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenues:        
Net product sales $ 38,213 $ 32,810 $ 114,316 $ 103,504
Cost of product sales 11,914 9,458 30,228 28,420
Gross profit 26,299 23,352 84,088 75,084
Operating expenses:        
Research and development 3,470 4,465 8,683 13,505
General and administrative 13,980 12,373 41,153 41,252
Sales and marketing 12,942 10,972 36,828 36,028
Total operating expenses 30,392 27,810 86,664 90,785
Loss from operations (4,093) (4,458) (2,576) (15,701)
Loss on debt extinguishment (11,339)   (11,339)  
Other expense, net (2,063) (390) (3,326) (1,542)
Net loss (17,495) (4,848) (17,241) (17,243)
Other comprehensive loss:        
Unrealized gain (loss) on short-term investments 1 48 (13) 27
Comprehensive loss $ (17,494) $ (4,800) $ (17,254) $ (17,216)
Basic net loss income per common share $ (0.1) $ (0.03) $ (0.11) $ (0.11)
Diluted net loss income per common share $ (0.1) $ (0.03) $ (0.11) $ (0.11)
Weighted average common shares outstanding, basic 170,348 152,830 159,524 152,213
Weighted average common shares outstanding, diluted 170,348 152,830 159,524 152,213